The company is not selling any securities under this prospectus and will not receive any proceeds from the sale of its common stock by the selling stockholder.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- Conduit Pharmaceuticals receives further patent approval for AZD1656
- Conduit Pharmaceuticals Announces Leadership Changes and Bylaws Update
- Conduit Pharmaceuticals announces new addition to autoimmune pipeline
- Conduit Pharmaceuticals Secures Funding and Modifies Debt Agreements
- Conduit Pharmaceuticals files $100M mixed securities shelf